DR REDDYS LABORATORIES LTD

RDY · XNYS

CIK 1135951fmd_0YNTRTKP9RF7EHXFN1425K832FManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Apr 01, 2015 to Mar 31, 2026, 11 periods

Income Statement · Annual · Millions · INR
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	154,708	140,809	142,028	153,851	174,600	189,722	214,391	245,879	279,164	325,535
Cost of revenue	62,427	62,453	65,724	70,421	80,591	86,645	100,551	106,536	115,557	135,107
Gross profit	92,281	78,356	76,304	83,430	94,009	103,077	113,840	139,343	163,607	190,428
Research and development	17,834	19,551	18,265	15,607	15,410	16,541	17,482	19,381	22,873	27,380
Selling, general and administrative	45,702	46,372	46,857	48,680	50,129	54,650	62,081	68,026	77,201	93,870
Operating income	29,619	13,498	11,917	20,888	15,993	24,280	29,476	57,144	67,729	71,843
Interest expense	4,959	781	817	1,163	983	970	958	1,428	1,711	2,829
Income before taxes	27,140	14,653	14,341	22,443	18,032	26,413	32,298	60,367	71,870	76,784
Income tax expense	7,127	2,614	4,535	3,648	(1,466)	9,175	8,730	15,300	16,186	19,539
Net income from continuing operations	20,013	12,039	9,806	18,795	19,498	17,238	23,568	45,067	55,684	57,245
Net income	20,013	12,039	9,806	18,795	19,498	17,238	23,568	45,067	55,684	56,544
Net income to common shareholders	20,013	12,039	9,806	18,795	19,498	17,238	23,568	45,067	55,684	56,544